Targeting SHMT2 genetically and pharmacologically inhibits nasopharyngeal carcinoma progression via disruption of the SHMT2-SAM-m6A regulatory circuit and TNF/NF-κB signaling

Biophysical Reports · Elsevier

Аннотация

Publication date: Available online 18 November 2026 Source: European Journal of Pharmacology Author(s): Qiguang Li, Jie Liu, Chong Zeng, Zhuoxian Rong, Qiaoli Lv, Ting Liang

Читать у издателя →

Похожие статьи